Zydus Lifesclences Limited Walk In Drive on 18th December 2024 (Wednesday) for freshers & Experienced
Zydus Lifesclences Limited
Zydus is one of the oldest players in the Indian formulations market and has gone onto become a prominent pharmaceutical manufacturer in India. Besides continuously improving its market presence and market share, the group has also expanded its portfolio by entering newer therapeutic areas.
Zydus Biologics
Zydus Biologics, a super-specialty centric business entity of Zydus Lifesciences Ltd., is engaged in manufacturing and commercialization of both, small molecule, biological drugs and vaccines intended for prevention and treatment of various diseases in the field of oncology, hepatology, nephrology, rheumatology, ophthalmology and bone health. With capabilities across the value chain – Drug development, manufacturing, distribution and commercialization, Zydus Biologics has emerged as one of the leading players in the biologics market and has a formidable presence in its participatory market. Zydus Biologics’ developmental capabilities cover fusion proteins, monoclonal antibodies, antibody drug conjugates and vaccines. It has a robust pipeline comprising of next generation biosimilars, and novel biologicals.
As part of its vision of being at the forefront of innovation led growth, Zydus Biologics has undertaken several pioneering initiatives like launching Exemptia, world’s first biosimilar of Adalimumab, Vaxiflu S – Indian’s first indigenously developed H1N1 vaccine for protection against swine flu, Vaxiflu 4 – India’s first quadrivalent influenza vaccine and ZyVac TCV – World’s second brand of typhoid conjugate vaccine.
In line with the group’s endeavour to improve access to healthcare for the public at large, Zydus Biologics has initiated various developmental programmes in the vaccines and diagnostics space. The aim is to cater to unmet needs of the people of this country in the field of immunization and detection of rare infectious diseases.
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is a leading Indian multinational pharmaceutical company headquartered in Ahmedabad. It is a fully integrated, global healthcare provider with a strong presence in the pharmaceutical value chain, from formulations and active pharmaceutical ingredients to animal healthcare products and wellness products.
Walk-in Interview
We are recruiting for API Mfg. Units at Ankleshwar
1) Production
Trainee Officer
Qualification: B.Sc / Diploma Chemical
Freshers (Graduation year 2023-2024)
2) Quality Assurance
IPQA Analyst
Qualification: B.Sc. / M.Sc. Chemistry
Experience: 2-3 years
Job Location: Ankleshwar
Date: 18th December 2024 (Wednesday)
Time: 1:00 pm to 4:00 pm
Venue:
Zydus Lifesciences Limited, Plot 291, GIDC – Ankleshwar, Dist – Bharuch, Gujarat – 393001
More update for job join our
1)What’s app group –https://chat.whatsapp.com/JAjYpaeFluN1RGi6Kvf8Dk
2)Teligram Channel – https://t.me/Pharmainjob
